Time-Matched, Linear Mixed-Effects Analysis of the Concentration-QT Relationship of Single-Agent Encorafenib in Patients With Unresectable or Metastatic BRAF V600-Mutant Melanoma or Metastatic Colorectal Cancer
|
Time-Matched, Linear Mixed-Effects Analysis of the Concentration-QT Relationship of Single-Agent Binimetinib in Patients With Cancer and Healthy Volunteers Pooled Across Multiple Studies
|
Population Pharmacokinetic Analysis of Encorafenib and Binimetinib in Patients With Unresectable or Metastatic BRAF V600-Mutant Melanoma
|
Model-Based Characterization of Tumor Dynamics in Patients With Melanoma Treated With Encorafenib + Binimetinib in the COLUMBUS Study
|